Home NDC 70934-131 acyclovir
Product NDC 70934-131
11-digit product format 709340131
Labeler code 70934
Product ID 70934-131_dc10ec8b-0330-095a-e053-2a95a90afcd1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form TABLET
Route ORAL
Labeler Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application ANDA204314
Marketing category ANDA
Marketing start 2018-06-06
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70934-131-14 70934013114 14 TABLET in 1 BOTTLE, PLASTIC (70934-131-14) 14 tablet 2019-05-13 0000-00-00 No No Current 70934-131-25 70934013125 25 TABLET in 1 BOTTLE, PLASTIC (70934-131-25) 25 tablet 2019-01-10 0000-00-00 No No Current 70934-131-30 70934013130 30 TABLET in 1 BOTTLE, PLASTIC (70934-131-30) 30 tablet 2018-06-06 0000-00-00 No No Current 70934-131-60 70934013160 60 TABLET in 1 BOTTLE, PLASTIC (70934-131-60) 60 tablet 2018-10-01 0000-00-00 No No Current